Shopping Cart
Remove All
Your shopping cart is currently empty
Sotevtamab (AB-16B5) is a monoclonal antibody targeting clusterin, an epithelial-mesenchymal transition inhibitor with antitumor activity, used in studies of colorectal cancer.
| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 1 mg | $247 | In Stock | In Stock | |
| 5 mg | $645 | In Stock | In Stock | |
| 10 mg | $987 | - | In Stock | |
| 25 mg | $1,530 | - | In Stock | |
| 50 mg | $1,980 | - | In Stock | |
| 100 mg | $2,790 | - | In Stock |
| Description | Sotevtamab (AB-16B5) is a monoclonal antibody targeting clusterin, an epithelial-mesenchymal transition inhibitor with antitumor activity, used in studies of colorectal cancer. |
| In vivo | Sotevtamab (5 mg/kg twice weekly) was able to inhibit tumor growth in mice with prostate and breast cancer. [1] |
| Synonyms | AB-16B5, AB16B5, 16B5 |
| Reactivity | Human |
| Application | FACS Functional assay |
| Antibody Type | Monoclonal |
| Endotoxin | < 1.0 EU/mg |
| Conjucates | Unconjugated |
| Uniprot ID |
| Cas No. | 2411526-47-9 |
| Color | Transparent |
| Appearance | Liquid |
| Storage | store at low temperature | -20°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.